Literature DB >> 20140750

A llama-derived gelsolin single-domain antibody blocks gelsolin-G-actin interaction.

Anske Van den Abbeele1, Sarah De Clercq, Ariane De Ganck, Veerle De Corte, Berlinda Van Loo, Sameh Hamdy Soror, Vasundara Srinivasan, Jan Steyaert, Joël Vandekerckhove, Jan Gettemans.   

Abstract

RNA interference has tremendously advanced our understanding of gene function but recent reports have exposed undesirable side-effects. Recombinant Camelid single-domain antibodies (VHHs) provide an attractive means for studying protein function without affecting gene expression. We raised VHHs against gelsolin (GsnVHHs), a multifunctional actin-binding protein that controls cellular actin organization and migration. GsnVHH-induced delocalization of gelsolin to mitochondria or the nucleus in mammalian cells reveals distinct subpopulations including free gelsolin and actin-bound gelsolin complexes. GsnVHH 13 specifically recognizes Ca(2+)-activated gelsolin (K (d) approximately 10 nM) while GsnVHH 11 binds gelsolin irrespective of Ca(2+) (K (d) approximately 5 nM) but completely blocks its interaction with G-actin. Both GsnVHHs trace gelsolin in membrane ruffles of EGF-stimulated MCF-7 cells and delay cell migration without affecting F-actin severing/capping or actin nucleation activities by gelsolin. We conclude that VHHs represent a potent way of blocking structural proteins and that actin nucleation by gelsolin is more complex than previously anticipated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140750     DOI: 10.1007/s00018-010-0266-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  68 in total

1.  A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.

Authors:  K Decanniere; A Desmyter; M Lauwereys; M A Ghahroudi; S Muyldermans; L Wyns
Journal:  Structure       Date:  1999-04-15       Impact factor: 5.006

2.  Measurement errors and their consequences in protein crystallography.

Authors:  Dominika Borek; Wladek Minor; Zbyszek Otwinowski
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-10-23

3.  Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications.

Authors:  Tong Cao; Boon Chin Heng
Journal:  Ann Clin Lab Sci       Date:  2005       Impact factor: 1.256

4.  Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.

Authors:  Ryosuke Nishio; Akira Matsumori
Journal:  Circ Res       Date:  2009-04-10       Impact factor: 17.367

5.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.

Authors:  K E Conrath; M Lauwereys; M Galleni; A Matagne; J M Frère; J Kinne; L Wyns; S Muyldermans
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

6.  Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer's disease.

Authors:  Lina Ji; Abha Chauhan; Jerzy Wegiel; Musthafa M Essa; Ved Chauhan
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.

Authors:  Kazuo Nishimura; Huei-Ju Ting; Yasunori Harada; Takashi Tokizane; Norio Nonomura; Hong-Yo Kang; Hong-Chiang Chang; Shuyuan Yeh; Hiroshi Miyamoto; Masaru Shin; Katsuyuki Aozasa; Akihiko Okuyama; Chawnshang Chang
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

8.  Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus.

Authors:  Anita Y Lam; Els Pardon; Konstantin V Korotkov; Wim G J Hol; Jan Steyaert
Journal:  J Struct Biol       Date:  2008-12-10       Impact factor: 2.867

9.  Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis.

Authors:  M Way; J Gooch; B Pope; A G Weeds
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

10.  Are the conserved sequences in segment 1 of gelsolin important for binding actin?

Authors:  M Way; B Pope; A G Weeds
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  22 in total

1.  Crystallization and preliminary X-ray diffraction analysis of a specific VHH domain against mouse prion protein.

Authors:  Romany N N Abskharon; Sameh H Soror; Els Pardon; Hassan El Hassan; Giuseppe Legname; Jan Steyaert; Alexandre Wohlkonig
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-11-26

2.  Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model.

Authors:  Wouter Van Overbeke; Adriaan Verhelle; Inge Everaert; Olivier Zwaenepoel; Joël Vandekerckhove; Claude Cuvelier; Wim Derave; Jan Gettemans
Journal:  Mol Ther       Date:  2014-07-15       Impact factor: 11.454

3.  Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies.

Authors:  Anneleen Steels; Adriaan Verhelle; Olivier Zwaenepoel; Jan Gettemans
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

4.  Nanobody-induced perturbation of LFA-1/L-plastin phosphorylation impairs MTOC docking, immune synapse formation and T cell activation.

Authors:  Sarah De Clercq; Olivier Zwaenepoel; Evelien Martens; Joël Vandekerckhove; Aude Guillabert; Jan Gettemans
Journal:  Cell Mol Life Sci       Date:  2012-09-23       Impact factor: 9.261

Review 5.  Single domain antibodies for the knockdown of cytosolic and nuclear proteins.

Authors:  Thomas Böldicke
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

6.  Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents.

Authors:  Masahito Yamagata; Joshua R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-13       Impact factor: 11.205

7.  PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration.

Authors:  Wojciech G Lesniak; Chengyan Chu; Anna Jablonska; Babak Behnam Azad; Olivier Zwaenepoel; Michal Zawadzki; Ala Lisok; Martin G Pomper; Piotr Walczak; Jan Gettemans; Miroslaw Janowski
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-03       Impact factor: 9.236

8.  Direct injection of functional single-domain antibodies from E. coli into human cells.

Authors:  Ana Blanco-Toribio; Serge Muyldermans; Gad Frankel; Luis Ángel Fernández
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

9.  Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using 99mTc-Modified Nanobodies and SPECT/CT.

Authors:  Adriaan Verhelle; Wouter Van Overbeke; Cindy Peleman; Rebecca De Smet; Olivier Zwaenepoel; Tony Lahoutte; Jo Van Dorpe; Nick Devoogdt; Jan Gettemans
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

10.  Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation.

Authors:  Jing Liu; Tim Hebbrecht; Toon Brans; Eef Parthoens; Saskia Lippens; Chengnan Li; Herlinde De Keersmaecker; Winnok H De Vos; Stefaan C De Smedt; Rabah Boukherroub; Jan Gettemans; Ranhua Xiong; Kevin Braeckmans
Journal:  Nano Res       Date:  2020-01-18       Impact factor: 8.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.